Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 26 results
ArgentinaX
Clear All
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa Phase3 Argentina
Austria
Belgium
Canada
Colombia
Czechia
France
Germany
Greece
Hungary
Malaysia
Mexico
Poland
Puerto Rico
Romania
Spain
Turkey (Türkiye)
United Kingdom
United States
View all

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis Phase3 Argentina
Australia
Belgium
Brazil
Canada
China
France
Georgia
Germany
India
Italy
Japan
Poland
Romania
Serbia
South Korea
Spain
Taiwan
United States
View all

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)

Hidradenitis Suppurativa Phase3 Argentina
Australia
Bulgaria
Canada
China
Colombia
Denmark
Germany
Greece
Italy
Malaysia
Mexico
Poland
Portugal
Slovakia
South Africa
Spain
Switzerland
Taiwan
United States
View all

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Familial Hypercholesterolemia - Heterozygous Phase3 Argentina
Austria
Belgium
Brazil
China
Czechia
France
Germany
Greece
Hong Kong
Hungary
Israel
Italy
Malaysia
Netherlands
Poland
Portugal
South Africa
Spain
Taiwan
Turkey (Türkiye)
United Kingdom
United States
View all

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Healthy Volunteers, Pulmonary Arterial Hypertension Phase1, Phase2 Argentina
Australia
Belgium
Brazil
Czechia
France
Germany
Greece
Italy
Latvia
Mexico
Poland
Portugal
Romania
Serbia
Spain
United Kingdom
United States
View all

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Asthma Phase3 Argentina
Austria
Bulgaria
Colombia
Czechia
Greece
Guatemala
Hungary
Italy
Mexico
Panama
Portugal
Romania
South Africa
Spain
Vietnam
View all

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Diffuse Cutaneous Systemic Sclerosis Phase2 Argentina
Austria
Belgium
Brazil
China
Colombia
France
Germany
Greece
Hungary
India
Italy
Japan
Malaysia
Mexico
Poland
Portugal
South Korea
Spain
Taiwan
Thailand
Turkey (Türkiye)
United Kingdom
United States
Vietnam
View all

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

Generalized Myasthenia Gravis Phase3 Argentina
Brazil
China
Denmark
France
Germany
Greece
Israel
Italy
Japan
Poland
Portugal
Serbia
South Korea
Spain
United Kingdom
United States
View all

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Systemic Lupus Erythematosus Phase3 Argentina
Australia
Brazil
Bulgaria
Canada
Chile
China
Colombia
Czechia
France
Germany
Guatemala
Hungary
India
Israel
Italy
Japan
Malaysia
Mexico
Poland
Portugal
Romania
South Africa
South Korea
Spain
Taiwan
Thailand
United States
View all

Asciminib Roll-over Study

Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase4 Argentina
Austria
Bulgaria
Canada
China
Czechia
France
Germany
Italy
Malaysia
Mexico
Oman
Poland
Portugal
Russia
South Korea
Spain
Turkey (Türkiye)
United Kingdom
United States
Vietnam
View all